Your browser doesn't support javascript.
loading
The prognostic value of IPI in patients with primary breast lymphoma, a multicenter retrospective study.
Feng, Kexin; Zhao, Shuangtao; Shang, Qingyao; Qiao, Guangdong; Liu, Jiaxiang; Yang, Chenxuan; Wei, Ya; Li, Yalun; Ren, Fei; Xuan, Lixue; Wang, Xiang; Wang, Xin.
Afiliação
  • Feng K; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republic of China.
  • Zhao S; Department of Thoracic Surgery, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China.
  • Shang Q; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republic of China.
  • Qiao G; Department of Breast Surgery, Yantai Yuhuangding Hospital, Yantai, 264000, China.
  • Liu J; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republic of China.
  • Yang C; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republic of China.
  • Wei Y; Department of Breast Surgery, An Yang Tumor Hospital, An Yang, 455001, Henan, China.
  • Li Y; Department of Breast Surgery, Yantai Yuhuangding Hospital, Yantai, 264000, China.
  • Ren F; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republic of China.
  • Xuan L; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republic of China. xuanlx@hotmail.com.
  • Wang X; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republic of China. xiangw@vip.sina.com.
  • Wang X; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republic of China. xinwang@vip.126.com.
Cancer Cell Int ; 22(1): 357, 2022 Nov 15.
Article em En | MEDLINE | ID: mdl-36376836
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Cell Int Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Cell Int Ano de publicação: 2022 Tipo de documento: Article